Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Inherited Retinal Disease > Retrospective study maps genetic landscape of leber congenital amaurosis
  • Inherited Retinal Disease

Retrospective study maps genetic landscape of leber congenital amaurosis

Ophthalmology 360

A recent retrospective study conducted at the inherited retinal disease (IRD) clinic at the University of Minnesota (UMN)/M Health System sheds light on the clinical characteristics and genetic variants present in a cohort of Leber congenital amaurosis (LCA) patients.

The study, aimed at understanding the nuances of LCA within the Midwest region of the United States, analyzed data from 33 non-syndromic patients and one patient with Joubert syndrome.

The research, which examined medical history, clinical examinations, and genetic testing results, revealed significant findings. Utilizing ocular coherence tomography (OCT) and fundus autofluorescence (FAF), the study monitored disease presentation, noting advanced photoreceptor loss in 85.7% of the patients. Additionally, all patients who underwent FAF exhibited findings indicative of either a ring of macular hypo/hyper autofluorescence or peripheral hypo-autofluorescence.

Electroretinogram (ERG) testing, performed when clinically indicated, revealed abnormal findings in all patients, underlining the severity and consistency of the disease manifestation within the cohort.

One of the pivotal aspects of the study was the genetic testing offered to all evaluated patients. Through next-generation sequencing (NGS) and subsequent genetic counseling, a diagnostic genetic test result was identified in 74.2% of the patients via NGS single-gene testing or panel testing. This highlights the importance of genetic analysis in understanding the underlying causes of LCA.

Reference
Sather R 3rd, Ihinger J, Simmons M, et al. The Clinical Findings, Pathogenic Variants, and Gene Therapy Qualifications Found in a Leber Congenital Amaurosis Phenotypic Spectrum Patient Cohort. Int J Mol Sci. 2024;25(2):1253. doi: 10.3390/ijms25021253. PMID: 38279252; PMCID: PMC10816538.

Share

Related Content

  • Inherited Retinal Disease

Patients with inherited retinal diseases face elevated risk of multiple ocular complications

  • Inherited Retinal Disease

Low-dose atropine shows limited effect on myopia progression in children with IRDs

  • Inherited Retinal Disease

Emerging imaging technologies offer hope for inherited retinal disease management

  • Inherited Retinal Disease

Emerging therapies and treatment for rare retinal diseases: a look at the pipeline

  • Inherited Retinal Disease

Breakthroughs in Gene Therapy and Diagnostics: Advancing Treatments and Understanding

  • Inherited Retinal Disease

Limited myopia progression in CSNB patients may guide treatment approaches

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon